Blake Flood
Impact in
- Immunology top 5%
- interferon and immune responses
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Emily F. Higgs (8 shared papers)Thomas F. Gajewski (8 shared papers)Thomas F. Gajewski (1 shared paper)Leticia Corrales (1 shared paper)Stefani Spranger (1 shared paper)Vyara Matson (1 shared paper)Shuyin Li (3 shared papers)Jason J. Luke (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Biopreservation and Biobanking (1 paper)Cell Research (1 paper)Cell Reports (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- United States
In The Last Decade
Blake Flood
7 papers receiving 689 citations
Blake Flood's Hit Papers
Peers
Comparison fields: 5 of 64
- Immunology 493
- Oncology 261
- Infectious Diseases 89
- Molecular Biology 228
- Cancer Research 42
Countries citing papers authored by Blake Flood
This map shows the geographic impact of Blake Flood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blake Flood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blake Flood more than expected).
Fields of papers citing papers by Blake Flood
This network shows the impact of papers produced by Blake Flood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blake Flood. The network helps show where Blake Flood may publish in the future.
Co-authors
The 25 scholars most cited alongside Blake Flood, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 310 | |
| 2 | STING pathway agonism as a cancer therapeutic Hit paper breakdown → | 2019 | 274 |
| 3 | 2021 | 105 | |
| 4 | 2021 | 5 | |
| 5 | 2020 | 1 | |
| 6 | 2020 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2025 | 0 | |
| 9 | Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection | 2020 | 0 |
| 10 | 2022 | 0 |
About Blake Flood
Blake Flood is a scholar working on Oncology, Infectious Diseases, Immunology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 10 papers that have together received 697 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), COVID-19 Clinical Research Studies (3 papers), Ferroptosis and cancer prognosis (3 papers), Immunotherapy and Immune Responses (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), CAR-T cell therapy research (3 papers), Immune Cell Function and Interaction (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Immunology (493 citations), Oncology (261 citations), Infectious Diseases (89 citations), Molecular Biology (228 citations) and Cancer Research (42 citations). Blake Flood has collaborated with scholars based in United States. Frequent co-authors include Emily F. Higgs, Thomas F. Gajewski, Thomas F. Gajewski, Leticia Corrales, Stefani Spranger, Vyara Matson, Shuyin Li, Jason J. Luke, Jovian Yu and Ken Hatogai. Their work appears in journals such as Clinical Cancer Research, Biopreservation and Biobanking, Cell Research, Cell Reports and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.